ArticleBMC public health2025
The association of cardiometabolic multimorbidity with depression and length of hospitalization: a population-based cross-sectional study among adults in Turkey.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- The impact of sensory impairment on cardiometabolic multimorbidity in middle-aged and older adults: the mediating role of depressive symptoms.European journal of medical research · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecent developments suggest a strong association between cardiometabolic multimorbidity, depression, and hospitalization. The aim of this study was to investigate the association of cardiometabolic multimorbidity with depression and the length of hospitalization among individuals aged 40 and older.
methodsThis study is based on the secondary analysis of data obtained from the 2022 Turkey Health Survey conducted by the Turkish Statistical Institute (TUIK). A weighted sample of 31,425,252 individuals aged 40 and over was analyzed. The dependent variables of the study are depression and hospitalization, while the independent variable is cardiometabolic multimorbidity. Other covariates include gender, age, education level, physical activity, body mass index, tobacco use, and alcohol use. The weights from the database provided by TUIK were used in the data analysis. The relationship between cardiometabolic multimorbidity and depression was investigated using univariate and multivariate logistic regression analysis.
resultOf the included participants, 51.2% were female and 35.5% were between the ages of 40-49. In Model 1, individuals with five cardiometabolic diseases had a 10-fold higher risk of developing depression compared to those with no diseases (OR: 10.0; 95% CI: 9.82-10.23). In Model 2, the risk of depression was 5.1 times higher in individuals with three diseases (OR: 5.1; 95% CI: 5.08-5.14), 5.83 times higher in those with four diseases (OR: 5.3; 95% CI: 5.78-5.88), and 14.6 times higher in individuals with five diseases (OR: 14.6; 95% CI: 14.36-14.99). Furthermore, as the number of cardiometabolic diseases increases, a significant increase in the length of hospitalization was observed (p < 0.001).
conclusionsThe findings of this study revealed that cardiometabolic multimorbidity may increase the risk of depression and the length of hospitalization in adults. These results may provide guidance for developing disease prevention and control strategies regarding cardiometabolic multimorbidity and associated factors in adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.